167 related articles for article (PubMed ID: 37845206)
21. Targeting focal adhesion kinase in cancer cells and the tumor microenvironment.
Murphy JM; Rodriguez YAR; Jeong K; Ahn EE; Lim SS
Exp Mol Med; 2020 Jun; 52(6):877-886. PubMed ID: 32514188
[TBL] [Abstract][Full Text] [Related]
22. IL-33 and ST2 mediate FAK-dependent antitumor immune evasion through transcriptional networks.
Serrels B; McGivern N; Canel M; Byron A; Johnson SC; McSorley HJ; Quinn N; Taggart D; Von Kreigsheim A; Anderton SM; Serrels A; Frame MC
Sci Signal; 2017 Dec; 10(508):. PubMed ID: 29208683
[TBL] [Abstract][Full Text] [Related]
23. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation.
Cox BD; Natarajan M; Stettner MR; Gladson CL
J Cell Biochem; 2006 Sep; 99(1):35-52. PubMed ID: 16823799
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo.
Liu TJ; LaFortune T; Honda T; Ohmori O; Hatakeyama S; Meyer T; Jackson D; de Groot J; Yung WK
Mol Cancer Ther; 2007 Apr; 6(4):1357-67. PubMed ID: 17431114
[TBL] [Abstract][Full Text] [Related]
25. FAK regulates Cdk2 in EGF-stimulated primary cultures of hepatocytes.
Flinder LI; Wierød L; Rosseland CM; Huitfeldt HS; Skarpen E
J Cell Physiol; 2013 Jun; 228(6):1304-13. PubMed ID: 23168795
[TBL] [Abstract][Full Text] [Related]
26. The effect of epidermal growth factor receptor variant III on glioma cell migration by stimulating ERK phosphorylation through the focal adhesion kinase signaling pathway.
Liu M; Yang Y; Wang C; Sun L; Mei C; Yao W; Liu Y; Shi Y; Qiu S; Fan J; Cai X; Zha X
Arch Biochem Biophys; 2010 Oct; 502(2):89-95. PubMed ID: 20650261
[TBL] [Abstract][Full Text] [Related]
27. FAK regulates intestinal epithelial cell survival and proliferation during mucosal wound healing.
Owen KA; Abshire MY; Tilghman RW; Casanova JE; Bouton AH
PLoS One; 2011; 6(8):e23123. PubMed ID: 21887232
[TBL] [Abstract][Full Text] [Related]
28. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.
Shi Q; Hjelmeland AB; Keir ST; Song L; Wickman S; Jackson D; Ohmori O; Bigner DD; Friedman HS; Rich JN
Mol Carcinog; 2007 Jun; 46(6):488-96. PubMed ID: 17219439
[TBL] [Abstract][Full Text] [Related]
29. FAK is required for c-Met/β-catenin-driven hepatocarcinogenesis.
Shang N; Arteaga M; Zaidi A; Stauffer J; Cotler SJ; Zeleznik-Le NJ; Zhang J; Qiu W
Hepatology; 2015 Jan; 61(1):214-26. PubMed ID: 25163657
[TBL] [Abstract][Full Text] [Related]
30. Kctd20 promotes the development of non-small cell lung cancer through activating Fak/AKT pathway and predicts poor overall survival of patients.
Zhang X; Zhou H; Cai L; Fan C; Liu Y; Wang L; Li Q; Miao Y
Mol Carcinog; 2017 Sep; 56(9):2058-2065. PubMed ID: 28398603
[TBL] [Abstract][Full Text] [Related]
31. Protein tyrosine phosphatase 1B targets focal adhesion kinase and paxillin in cell-matrix adhesions.
González Wusener AE; González Á; Perez Collado ME; Maza MR; General IJ; Arregui CO
J Cell Sci; 2021 Oct; 134(20):. PubMed ID: 34553765
[TBL] [Abstract][Full Text] [Related]
32. Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases.
Shi Q; Bao S; Song L; Wu Q; Bigner DD; Hjelmeland AB; Rich JN
Oncogene; 2007 Jun; 26(28):4084-94. PubMed ID: 17213807
[TBL] [Abstract][Full Text] [Related]
33. RSK activation via ERK modulates human colon cancer cells response to PTHrP.
Calvo N; Carriere P; Martin MJ; Gentili C
J Mol Endocrinol; 2017 Jul; 59(1):13-27. PubMed ID: 28385776
[TBL] [Abstract][Full Text] [Related]
34. Direct interaction of v-Src with the focal adhesion kinase mediated by the Src SH2 domain.
Xing Z; Chen HC; Nowlen JK; Taylor SJ; Shalloway D; Guan JL
Mol Biol Cell; 1994 Apr; 5(4):413-21. PubMed ID: 8054685
[TBL] [Abstract][Full Text] [Related]
35. Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility.
Mañes S; Mira E; Gómez-Mouton C; Zhao ZJ; Lacalle RA; Martínez-A C
Mol Cell Biol; 1999 Apr; 19(4):3125-35. PubMed ID: 10082579
[TBL] [Abstract][Full Text] [Related]
36. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells.
Fernandis AZ; Prasad A; Band H; Klösel R; Ganju RK
Oncogene; 2004 Jan; 23(1):157-67. PubMed ID: 14712221
[TBL] [Abstract][Full Text] [Related]
37. CD99-Derived Agonist Ligands Inhibit Fibronectin-Induced Activation of β1 Integrin through the Protein Kinase A/SHP2/Extracellular Signal-Regulated Kinase/PTPN12/Focal Adhesion Kinase Signaling Pathway.
Lee KJ; Kim Y; Yoo YH; Kim MS; Lee SH; Kim CG; Park K; Jeoung D; Lee H; Ko IY; Hahn JH
Mol Cell Biol; 2017 Jul; 37(14):. PubMed ID: 28483911
[TBL] [Abstract][Full Text] [Related]
38. CD99 inhibits CD98-mediated β1 integrin signaling through SHP2-mediated FAK dephosphorylation.
Lee KJ; Yoo YH; Kim MS; Yadav BK; Kim Y; Lim D; Hwangbo C; Moon KW; Kim D; Jeoung D; Lee H; Lee JH; Hahn JH
Exp Cell Res; 2015 Aug; 336(2):211-22. PubMed ID: 26172215
[TBL] [Abstract][Full Text] [Related]
39. Molecular basis of reduced LAIR1 expression in childhood severe malarial anaemia: Implications for leukocyte inhibitory signalling.
Achieng AO; Guyah B; Cheng Q; Ong'echa JM; Ouma C; Lambert CG; Perkins DJ
EBioMedicine; 2019 Jul; 45():278-289. PubMed ID: 31257148
[TBL] [Abstract][Full Text] [Related]
40. Involvement of ROS-alpha v beta 3 integrin-FAK/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia.
Xu CS; Wang ZF; Huang XD; Dai LM; Cao CJ; Li ZQ
J Transl Med; 2015 Mar; 13():95. PubMed ID: 25889845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
